AzTrials
AzTrials

Rectal CancerSAVENCT01006577

Side-to-end Anastomosis Versus Colon J Pouch for Reconstruction After Low Anterior Resection for Rectal Cancer (SAVE)

A study testing side-to-end anastomosis and colon j pouch in people with Rectal Cancer, run by Charite University, Berlin, Germany at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Primary hypothesis: Side-to-end anastomosis is non-inferior to colon J pouch for reconstruction after low anterior resection for rectal cancer in fecal incontinence (Wexner score). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Rectal Cancer
What is being tested?
side-to-end anastomosis and colon j pouch
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
306 participants
Where
1 siteGermany
Study dates
Jun 2010to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients with histological proven middle to low rectal cancer (< 12 cm from the anal verge) requiring low anterior resection with TME
  • with or without (neo)-adjuvant radiochemotherapy
  • age ≥18 years
  • normal preoperative sphincter status (Wexner score = 0)

Who cannot join

  • synchronous metastasis
  • age > 80 years
  • previous colon resection
  • inflammatory bowel disease
  • previous pelvic malignant tumor
  • no anterior resection/ TME possible
Show all 10Show fewer
  • synchronous other malignant disease
  • emergency operation
  • local excision by colonoscopy possible
  • unability to complete or comprehend the preoperative questionnaire

Trial locations and contacts

1 site in 1 country.

Johannes C Lauscher, MD contact

0049 30 8445 2543

johannes.lauscher@charite.de

Jörg-Peter Ritz, PD Dr. contact

0049 30 8445 2503

joerg-peter.ritz@charite.de

Germany1 site
  • Charité Campus Benjamin Franklin; Hindenburgdamm 30

    Berlin, State of Berlin, D-12200

    Johannes C Lauscher, MD, 0049 30 8445 2543, johannes.lauscher@charite.de

Other trials in Germany

About this study

Primary hypothesis: Side-to-end anastomosis is non-inferior to colon J pouch for reconstruction after low anterior resection for rectal cancer in fecal incontinence (Wexner score).

Research questions: Are there differences between side-to-end anastomosis and colon J pouch in

  • bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
  • quality of life
  • sexual function
  • urinary function
  • postoperative complications
  • operation time/ institutional costs
Read the detailed description

Experimental intervention: Low anterior resection for rectal cancer < 12 cm from the anal verge with total mesorectal excision (TME), ligation of the inferior mesenteric artery close to the aorta, mobilization of the splenic flexure, radical lymph node dissection and side-to-end colorectal/ coloanal anastomosis (STE). The blind end of the descending colon (3-5 cm long) is closed with a linear stapler. Stapling of the anastomosis is done by introducing the stapler from the anus by the assistant surgeon while the surgeon is holding the descending colon in the correct position. The anastomosis is performed on the antimesenteric aspect of the descending colon. The length of the blind end is measured and the integrity of the anastomosis is tested intraoperatively. The intended minimal distal clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3 months postoperatively.

Control intervention: Low anterior resection for rectal cancer with total mesorectal excision (TME), ligation of the inferior mesenteric artery close to the aorta, mobilization of the splenic flexure, radical lymph node dissection and colon J pouch rectal/colon J pouch anal anastomosis (CJP). The colon J Pouch is formed by the descending colon by stapling with a defined pouch limb length of 5-6 cm, which is measured intraoperatively. The stapling is done by introducing the stapler from the anus by the assistant surgeon while the surgeon is holding the descending colon in the correct position. The integrity of the anastomosis is tested intraoperatively. The intended minimal distal clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3 months postoperatively.

Follow-up per patient: 24 months postoperatively

Conditions
Rectal Cancer
Being tested
side-to-end anastomosis, colon j pouch
Keywords
rectal cancer, side-to-end anastomosis, colon J pouch, fecal incontinence, anorectal function, Are there differences between side-to-end anastomosis and colon J pouch in, bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation), quality of life, postoperative complications, operation time/ institutional costs
Medical subject headings
Rectal Neoplasms, Fecal Incontinence, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • side-to-end anastomosisProcedure or surgery

    Low anterior resection for rectal cancer < 12 cm from the anal verge with total mesorectal excision (TME), ligation of the inferior mesenteric artery close to the aorta, mobilization of the splenic flexure, radical lymph node dissection and side-to-end colorectal/ coloanal anastomosis (STE). The blind end of the descending colon (3-5 cm long) is closed with a linear stapler. Stapling of the anastomosis is done by introducing the stapler from the anus by the assistant surgeon while the surgeon is holding the descending colon in the correct position. The anastomosis is performed on the antimesenteric aspect of the descending colon. The length of the blind end is measured and the integrity of the anastomosis is tested intraoperatively. The intended minimal distal clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3 months postoperatively.

  • colon j pouchProcedure or surgery

    Low anterior resection for rectal cancer with total mesorectal excision (TME), ligation of the inferior mesenteric artery close to the aorta, mobilization of the splenic flexure, radical lymph node dissection and colon J pouch rectal/colon J pouch anal anastomosis (CJP). The colon J Pouch is formed by the descending colon by stapling with a defined pouch limb length of 5-6 cm, which is measured intraoperatively. The stapling is done by introducing the stapler from the anus by the assistant surgeon while the surgeon is holding the descending colon in the correct position. The integrity of the anastomosis is tested intraoperatively. The intended minimal distal clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3 months postoperatively.

Study groups in NCT01006577
Study groupRoleWhat they receive
colon j pouchOtherControl intervention: Low anterior resection for rectal cancer with total mesorectal excision (TME), ligation of the inferior mesenteric artery, mobilization of the splenic flexure, radical lymph node dissection and colon J pouch rectal/colon J pouch anal anastomosis (CJP). The colon J Pouch is formed by the descending colon by stapling. The intended minimal distal clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3 months postoperatively.
Receives: Procedure: colon j pouch
side-to-end anastomosis (STE)ExperimentalExperimental intervention: Low anterior resection for rectal cancer < 12 cm from the anal verge with total mesorectal excision (TME), ligation of the inferior mesenteric artery, mobilization of the splenic flexure, radical lymph node dissection and side-to-end colorectal/ coloanal anastomosis (STE). The blind end of the descending colon is closed with a linear stapler. The length of the blind end is measured and the integrity of the anastomosis is tested intraoperatively. The intended minimal distal clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3 months postoperatively.
Receives: Procedure: side-to-end anastomosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Side-to-end anastomosis is not inferior not colon J pouch in terms of fecal incontinence. fecal incontinence (Wexner score)

    Measured: First patient in to last patient out: 03/2010 -03/2015

Secondary outcomes (9)
  1. anorectal function

    Measured: 03/2010-03/2015

  2. quality of life

    Measured: 03/2010-03/2015

  3. postoperative complications

    Measured: 03/2010-03/2015

  4. sexual function

    Measured: 03/2010-03/2015

  5. urinary function

    Measured: 03/2010-03/2015

  6. operation time

    Measured: 03/2010-03/2015

  7. institutional costs

    Measured: 03/2010-03/2015

  8. local recurrence

    Measured: 03/2010-03/2015

  9. cancer related deaths

    Measured: 03/2010-03/2015

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 2009 (estimated)
  2. Study startJun 2010
  3. Primary completionJul 2015 (estimated)
  4. Study completionOct 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
306 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01006577
Sponsor's protocol ID
EA4/105/08
Acronym
SAVE
Status last verified
Nov 2009
First submitted
19 Oct 2009
Last updated
3 Nov 2009
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing side-to-end anastomosis and colon j pouch in people with Rectal Cancer, run by Charite University, Berlin, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Nov 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Johannes C Lauscher, MD (0049 30 8445 2543, johannes.lauscher@charite.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Side-to-end anastomosis is not inferior not colon J pouch in terms of fecal incontinence. fecal incontinence (Wexner score) (time frame: First patient in to last patient out: 03/2010 -03/2015). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in